Thanks to the most advanced bacterial DNA sequencing techniques (Next Generation Sequencing), it is now possible to achieve a complete and reliable identification of the intestinal microbiota.
The intestinal microbiota – also known as the bacterial flora – is a true organ, consisting of a community of symbiotic microorganisms (bacteria, fungi, viruses, and protists) that reside in the gastrointestinal tract. It houses 80% of our immune system, can weigh almost 1.5 kg, and has a unique composition in every individual, like fingerprints.
The role of a healthy microbiota is to maintain physiological and metabolic well-being, contributing to proper digestion, the success of nutritional and pharmacological therapies, and preventing the onset of obesity, type II diabetes, metabolic syndrome, inflammatory bowel diseases, diverticula, colorectal cancer, rheumatoid arthritis, and allergies.
There are also particular conditions in which this analysis can guide a precise therapeutic approach.
A stool sample is required, similar to a simple chemical-physical or cultural examination, using a specific KIT.
Thanks to the most advanced bacterial DNA sequencing techniques (Next Generation Sequencing) extracted from fecal material, it is now possible to achieve a complete and reliable identification of the intestinal microbiota. In addition to identifying the bacterial species present, we are also able to provide an overall health status of the microbiota (or dysbiosis), its efficiency in producing certain beneficial or harmful substances, the adequacy of the microbiota in relation to some fundamental functions it performs, as well as the microbiota’s susceptibility to inflammatory bowel diseases, metabolic diseases, and aging.
This results in an impressive amount of data, a true identity card of the microbiota, the Microbiopassport®.
The sequencing results and the subsequent bioinformatic and statistical analysis of the Microbiopassport® data are available about 30 days after sampling.